Female sexual dysfunction, or FSD, has long been under-diagnosed and under-treated in clinical practice. But in recent months, notable leaders in women's health have stepped forward to push for new recognition and prioritization of this disorder to the forefront of the FDA. On this program, host Dr. Matt Birnholz is joined by one of those leaders who helped jumpstart this critical development: Dr. Michael Krychman, Executive Director of the Southern California Center for Sexual Health in Newport Beach, CA.
